Search NASA⌕ Search

SEARCH · Search NASA

Results for “SYNCHROCYCLOTRONS”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 records

New laser setup for the selective isotope production and investigation in a laser ion source at the IRIS (Investigation of Radioactive Isotopes on Synchrocyclotron) facility

New laser installation for the resonance ionization spectroscopy in a laser ion source and for rare isotope production has been recently put into operation at the IRIS (Investigation of Radioactive Isotopes on Synchrocyclotron) facility (Petersburg Nuclear Physics Institute, Gatchina). This is a significant improvement of a previous target-laser ion source device of the IRIS mass-separator, working on-line with 1 GeV proton beam of PNPI (Petersburg Nuclear Physics Institute) synchrocyclotron. It makes possible for us to get the isobarically clean radioactive isotope beams of a great number of chemical elements. New laser setup provides the two- or three-resonance step ionization in the range of wavelength of 265-850 nm. The first results obtained at the laser setup for Tl isotopes are presented.

07 ISOTOPE AND RADIATION SOURCES↗

Brief overview of the creation of the synchrocyclotron at the hydrotechnical laboratory of the USSR Academy of Sciences and first results of physical studies: Review of archival documents

A review of the archive’s documents on the main stages of the creation of the synchrocyclotron at the Hydrotechnical Laboratory (now known as the Dzhelepov Laboratory of Nuclear Problems) is presented. The review is based on minutes of the Special Committee and Scientific and Technical Council (NTS), which belongs to the First Chief Directorate (PGU) concerning the era of the Soviet atomic project (1945–1953). The analysis of these minutes has enabled us to prepare a chronicle of events that deal with the creation of the synchrocyclotron, as well as the discussion of the project and its place of construction, the research and development program, and so on. The minutes of two NTS meetings dated May 5 and 12, 1952 are devoted to discussing the results the research and development program in 1950–1951. The minutes of NTS meetings have not been published previously.

43 PARTICLE ACCELERATORS↗

Particle acceleration in a variable-energy synchrocyclotron by a single-tuned variable-frequency drive

Ions are released over time from an ion source into a beam area proximate a central axis. A radiofrequency (RF) system with a variable frequency and variable voltage accelerates the ions in orbiting trajectories expanding outward from the central axis. The ions are accelerated to different extraction energy levels within a given design range at a shared extraction radius from the central axis. An RF-frequency versus ion-time-of-flight scenario is set such that the frequency versus time scenario is the same for any ion extraction energy from the given design range, and a constant-or-variable-RF-voltage versus ion-time-of-flight scenario is adjusted to provide ion acceleration from injection to extraction for ions with different respective extraction energy levels within the given design range; and the ions are extracted at the different energy levels at the shared extraction radius.

Radovinsky, Alexey↗

First multi-institutional systematic comparison of the neutron ambient dose equivalent produced by proton therapy systems

Objective. Isochronous cyclotrons, synchrocyclotrons, and synchrotrons are used to accelerate protons for proton therapy. An accurate measurement of neutron doses generated by these accelerators and associated delivery systems and its clinical relevance requires systematic protocols and proper neutron dosimetry for a meaningful assessment. We present the first comprehensive comparison of neutron ambient dose equivalent (H*(10)) produced by clinically operational proton therapy systems. Approach. Treatment plans with 10 cm modulation-depth and ranges of 10 cm (R10M10) and 25 cm (R25M10) were created to cover a 10 × 10 × 10 cm 3 water target. The pencil beam scanning proton therapy machines studied were: two gantry-mounted synchrocyclotrons (Hyperscan, Mevion, half-gantry), two isochronous cyclotrons (ProBeam, Varian, full-gantry), one isochronous cyclotron (Proteus, IBA, full-gantry), and two synchrotrons (PROBEAT, Hitachi, full- and half-gantry). Proton beams were delivered to 30 × 30 × 40 cm 3 plastic water phantoms. WENDI-II and LUPIN-BF3-NP neutron rem-meters were positioned at three angles (0°, 45°, 90°) relative to the beam direction to measure the neutron H*(10) at distances between 50–300 cm from the isocenter. Main results. H*(10) showed dependence on beam energy, machine type, and measurement location. The highest reading was for the gantry-mounted synchrocyclotron, whereas other systems produced approximately comparable neutron doses. In all cases, the H*(10) reduced with distance from the isocenter. The H*(10) drop at 2 m distance compared to that at 0.5 m was a factor of ∼5 for the gantry-mounted synchrocyclotron whereas in other systems the decrease was a factor of 10. The WENDI-II device suffered from dead-time-associated under-estimation of the dose by a factor of ∼2–3 under the synchrocyclotron beam due to its high dose-per-pulse. However, WENDI-II and LUPIN-BF3-NP results were within reasonable agreement in isochronous cyclotron and synchrotron beams, indicating that both devices are suitable for those systems. Significance. Neutron H*(10) is dependent on various parameters including beam energy, measurement location, as well as machine design. Caution must be exercised in choosing the appropriate neutron-dose-measurement device to be used for low-duty-factor, particularly in high-instantaneous-rate proton delivery systems. By delivering the same volumetric proton dose across different machines, this work provides a benchmark for inter-system comparisons and serves as a foundation for future studies.

LUPIN↗

TH-CD-201-10: Highly Efficient Synchronized High-Speed Scintillation Camera System for Measuring Proton Range, SOBP and Dose Distributions in a 2D-Plane

Purpose: Proton therapy (PT) delivery is complex and extremely dynamic. Therefore, quality assurance testing is vital, but highly time-consuming. We have developed a High-Speed Scintillation-Camera-System (HS-SCS) for simultaneously measuring multiple beam characteristics. Methods: High-speed camera was placed in a light-tight housing and dual-layer neutron shield. HS-SCS is synchronized with a synchrocyclotron to capture individual proton-beam-pulses (PBPs) at ∼504 frames/sec. The PBPs from synchrocyclotron trigger the HS-SCS to open its shutter for programmed exposure-time. Light emissions within 30×30×5cm3 plastic-scintillator (BC-408) were captured by a CCD-camera as individual images revealing dose-deposition in a 2D-plane with a resolution of 0.7mm for range and SOBP measurements and 1.67mm for profiles. The CCD response as well as signal to noise ratio (SNR) was characterized for varying exposure times, gains for different light intensities using a TV-Optoliner system. Software tools were developed to analyze ∼5000 images to extract different beam parameters. Quenching correction-factors were established by comparing scintillation Bragg-Peaks with water scanned ionization-chamber measurements. Quenching corrected Bragg-peaks were integrated to ascertain proton-beam range (PBR), width of Spared-Out-Bragg-Peak (MOD) and distal.

07 ISOTOPE AND RADIATION SOURCES↗

Compact, Low-Cost, Light-Weight, Superconducting, Ironless Cyclotrons for Hadron Radiotherapy (Final Report)

This is the final report of a conceptual design study to demonstrate the feasibility of an ironless, superconducting synchrocyclotron for use as a particle accelerator in the clinical treatment of cancer using proton beam radiotherapy (PBRT). Furthermore, the ironless synchrocyclotron approach can be scaled up to accelerate light ions up to carbon, offering significant treatment advantages over conventional proton therapies, and offers a path for more rapid introduction of this technology to clinical uses.

43 PARTICLE ACCELERATORS↗

Compact, Low-Cost, Light-Weight, Superconducting, Ironless Cyclotrons for Hadron Radiotherapy

Superconducting cyclotrons are increasingly employed for proton beam radiotherapy treatment (PBRT). The use of superconductivity in a cyclotron design can reduce its mass by an order of magnitude and size by a factor of 3-4 over conventional resistive magnet technology, yielding significant reduction in overall cost of the device, the accelerator vault, and its infrastructure, as well as reduced operating costs. At MIT, previous work was focused on developing a very high field (9 T at the pole face) superconducting synchrocyclotron that resulted in a highly compact device that is about an order of magnitude lighter, and much smaller in diameter than a conventional, resistive cyclotron. The results of the study reported here were focused on a conceptual design for a compact superconducting synchrocyclotron to demonstrate the possibility to further reduce its weight by almost another order of magnitude by eliminating all iron from the device. In the absence of magnetic iron poles, the magnetic field profile in the beam gap is achieved through a set of main superconducting split pair coils energized in series with a set of distributed field-shaping superconducting coils. External magnetic field shielding is achieved through a set of outer, superconducting ring coils, also connected in series with the other coils, to cancel the stray magnetic field. These shielding coils replace the heavy iron yoke which is the conventional method to return the magnetic flux. It is noted that the 10 Gauss surface is located at a radius of about 3.5 m comparable in both ironless and conventional devices, even in the absence of iron in the ironless device. An important result from eliminating all magnetic iron in the flux circuit is the resulting linear relationship between the operating current and the magnetic field intensity. In the case with iron, the saturation of the magnetic field forces operation at one value of magnetic field. This feature design then enables continuous beam energy variation without the use of an energy degrader, thus eliminating secondary radiation during the in-depth beam scanning, increasing the ion current delivered to the patient and improving the beam quality. The beam energy is determined by the magnetic field strength at the extraction radius, and changing the field enables selection of the final beam energy. The magnetic field can be adjusted while maintaining the needed radial field profile.

Minervini, Joseph V.↗

Proton Therapy At Siteman Cancer Center: The State Of The Art

Barnes-Jewish Hospital is on the verge of offering proton radiation therapy to its patients. Those treatments will be delivered from the first Monarch 250, a state-of-the-art cyclotron produced by Still River Systems, Inc., Littleton, MA. The accelerator is the world's first superconducting synchrocyclotron, with a field-strength of 10 tesla, providing the smallest accelerator for high-energy protons currently available. On May 14, 2010 it was announced that the first production unit had successfully extracted 250 MeV protons. That unit is scheduled for delivery to the Siteman Cancer Center, an NCI-designated Comprehensive Cancer Center at Washington University School of Medicine. At a weight of 20 tons and with a diameter of less than 2 meters the compact cyclotron will be mounted on a gantry, another first for proton therapy systems. The single-energy system includes 3 contoured scatterers and 14 different range modulators to provide 24 distinct beam delivery configurations. This allows proton fields up to 25 cm in diameter, with a maximum range from 5.5 to 32 cm and spread-out-Bragg-peak extent up to 20 cm. Monte Carlo simulations have been run using MCNPX to simulate the clinical beam properties. Those calculations have been used to commission a commercial treatment planning system prior to final clinical measurements. MCNPX was also used to calculate the neutron background generated by protons in the scattering system and patient. Additional details of the facility and current status will be presented.

43 PARTICLE ACCELERATORS↗

Startup of the Kling Center for Proton Therapy

In November of 2011 Mevion Medical Systems (formerly Still River Systems) delivered the Mevion S250 proton therapy system accelerator to the Kling Center for Proton Therapy at the Siteman Cancer Center in Saint Louis. The Mevion system is unique, with an in-room gantry-mounted superconducting synchrocyclotron. This is the first true single-room proton therapy system and it has a greatly reduced size as well as cost. A month after its arrival, the installation was complete and the superconducting magnet was ramped up to full current ({approx}2000 amperes). In March of 2012, full energy beam (250 MeV) was extracted and radiation surveys were performed to verify the shielding. Once that was shown to be sufficient, Mevion began fine-tuning the system to provide a highly isocentric beam from the 50 ton system. In June of 2012 the field-shaping system (energy degraders, contoured scatterers and range modulators) were installed and measurements of the clinical beam properties commenced. Monte Carlo simulations (MCNPX) have been performed for the system and validated with beam measurements done at the factory. These simulations have been used for a preliminary commissioning of our treatment planning system. Additionally, predictions of the neutron background have been made and validated with factory measurements. Final commissioning of the treatment planning system and verification of the neutron background will be accomplished with measurements made later in 2012. Based on current progress, patient treatments are scheduled to begin in late 2012. Beam and radiation background data will be presented.

43 PARTICLE ACCELERATORS↗

SU-E-T-590: An Activation Study of Materials and Devices Present in a Proton Treatment Room

Purpose: The use of protons for radiation therapy is growing rapidly. One consequence of protons interacting with different media is activation. These nuclear reactions induced by the protons, scattered neutrons, and gamma rays, activate different materials encountered, particularly by the therapists. The purpose of this study was to examine the derived nuclides from the activation, and also the decay rate. Methods: The study was conducted in our proton therapy facility. Protons are derived from a synchrocyclotron and pass through field shipping systems, apertures, and range compensators to define the beam within the patient.Included materials of concerns measured; the patient support couch, sheet rock in the wall, solid plastics used for quality assurance and dosimetry, and the passive scattering system itself, which includes brass apertures, and Lucite or blue wax compensators. All devices were studied post irradiation using gamma spectroscopy to determine the nuclides, and a sodium iodine scintillation detector to measure decay, particularly when the dose rate fell to background levels. Results: We have also determined from the measurements we will maintain brass apertures for three months before sending them for scrap. Some of the radionuclides arrived from these measurements included Na-22 for the blue wax compensator, C1-34m for the sheetrock, and Sc-44 and Co-60 for the brass apertures. We found compensators made out of Lucite or wax decayed to background in 2 hours. The patient support couch decayed to background in approximately 40 minutes, and sheet rock decayed in 80 minutes. In terms of the aperture layers, the most proximal aperture slab had much higher activity than the distal slab. Also the proximal sides of the slabs were much more activate than the distal. Conclusion: We have given proper instruction to therapists performing quality assurance in terms of the handled plastics, and to handle apertures rapidly as possible.

07 ISOTOPE AND RADIATION SOURCES↗

Modern compact accelerators of cyclotron type for medical applications

Ion beam therapy and hadron therapy are types of external beam radiotherapy. Recently, the vast majority of patients have been treated with protons and carbon ions. Typically, the types of accelerators used for therapy were cyclotrons and synchrocyclotrons. It is intuitively clear that a compact facility fits best to a hospital environment intended for particle therapy and medical diagnostics. Another criterion for selection of accelerators to be mentioned in this article is application of superconducting technology to the magnetic system design of the facility. Compact isochronous cyclotrons, which accelerate protons in the energy range 9–30 MeV, have been widely used for production of radionuclides. Energy of 230 MeV has become canonical for all proton therapy accelerators. Similar application of a carbon beam requires ion energy of 430 MeV/u. Due to application of superconducting coils the magnetic field in these machines can reach 4–5 T and even 9 T in some cases. Medical cyclotrons with an ironless or nearly ironless magnetic system that have a number of advantages over the classical accelerators are in the development stage. In this work an attempt is made to describe some conceptual and technical features of modern accelerators under consideration. The emphasis is placed on the magnetic and acceleration systems along with the beam extraction unit, which are very important from the point of view of the facility compactness and compliance with the strict medical requirements.

43 PARTICLE ACCELERATORS↗

Final Technical Report for the ProNova Solutions contribution to: Compact, low-cost, light-weight, superconducting, ironless cyclotrons for hadron radiotherapy

ProNova Solutions, LLC is a collaborator with the primary PI for this project, Dr. Joseph V. Minervini, Head of the Magnets and Cryogenics group at the Massachusetts Institute of Technology, Plasma Science and Fusion Center. The purpose of the grant was to develop the conceptual design for a superconducting ironless synchrocyclotron suitable for hadron therapy. Such a design could ultimately be extended to light ions such as Helium and Carbon which are being studied at centers around the world. The ProNova efforts have been led by Co-PI Laddie Derenchuk and by Joe Matteo, company president. ProNova efforts will be described in this Final Technical Report, other goals and efforts by the MIT group can be referenced in the MIT Final Technical Report. ProNova’s primary goals as defined in the Project Narrative were to “defin[e] specifications necessary to meet the current and future demands of particle therapy based on ProNova’s clinical experience.” In addition, ProNova was to “focus on ion source, RF, vacuum, and mechanical subsystem conceptual designs”. This report will describe ProNova’s contributions to this project.

43 PARTICLE ACCELERATORS↗

Changes in the mean square charge radii and electromagnetic moments of neutron-deficient Bi isotopes

In-source laser spectroscopy experiments for neutron deficient bismuth isotopes at the 306.77 nm atomic transition were carried out at the IRIS (Investigation of Radioactive Isotopes on Synchrocyclotron) facility of Petersburg Nuclear Physics Institute (PNPI). New data on isotope shifts and hyperfine structure for {sup 189–198,} {sup 211}Bi isotopes and isomers were obtained. The changes in the mean-square charge radii and the magnetic moment values were deduced. Marked deviation from the nearly spherical behavior for ground states of bismuth isotopes at N < 109 is demonstrated, in contrast to the lead and thallium isotopic chains. The big isomer shift between I = 1/2 (intruder) and I = 9/2 (normal) states for odd Bi isotopes (A = 193, 195, 197) was found.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Investigation of near-threshold eta-meson production in the reaction {pi}{sup -}p{yields} {eta}n

Differential and total cross sections for eta-meson production in the reaction {pi}{sup -}p {yields} {eta}n were measured within the experimental program eta-meson physics implemented in the pion channel of the synchrocyclotron of the Petersburg Nuclear Physics Institute (PNPI, Gatchina). These measurements were performed at incident-pion momenta (700, 710, 720, and 730 MeV/c) in the vicinity of the threshold for the process under study by using the neutral-meson spectrometer designed and created at the Meson Physics Laboratory of PNPI. It is shown that, in the immediate vicinity of the threshold (685 MeV/c), the process of eta-meson production proceeds predominantly via S{sub 11}(1535)-resonance formation followed by the decay S{sub 11}(1535) {yields} {eta}n (the respective branching fraction is Br Almost-Equal-To 60%), but that, as the momentum of incident pions increases, the role of the D wave becomes ever more important. A detailed analysis of this effect indicates that it is due to the increasing contribution of the D{sub 13}(1520) resonance. Although the branching fraction of the decay of this resonance through the {eta}n channel is assumed to be very small (BR Almost-Equal-To 0.24%), the effect is enhanced owing to the interference between the D wave and the dominant resonance S{sub 11}(1535).

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗

Shape evolution for neutron-deficient bismuth isotopes studied by resonance laser ionization spectroscopy

In-source laser spectroscopy experiments for bismuth isotopes at the 306.77 nm atomic transition has been carried out at the IRIS (Investigation of Radioactive Isotopes at Synchrocyclotron) facility of Petersburg Nuclear Physics Institute. New data on isotope shifts for {sup 189–198,211}Bi isotopes and isomers have been obtained. The changes in the mean-square charge radii were deduced. The large isomer shift has been observed for the intruder isomer states of Bi with spin I = 1/2 (A = 193, 195, 197). This testifies to the shape coexistence in these nuclei with the intruder isomer states more deformed than the ground states. Marked deviation from the nearly spherical behavior for ground states of the even-neutron Bi isotopes at N < 109 is demonstrated, in contrast to the Pb and Tl isotopic chains.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗

Spallation neutron source GNEIS

A brief description of the spallation pulsed neutron source and neutron TOF spectrometer GNEIS based on the 1 GeV proton synchrocyclotron of PNPI in Gatchina is presented. The main parameters of the GNEIS are given in comparison with the analogous world-class facilities. The experimental capabilities of the GNEIS are demonstrated by the examples of some nuclear physics and applied research experiments carried out during four decades of its operation.

43 PARTICLE ACCELERATORS↗

R -Matrix Analysis and Statistical Properties of Dysprosium Isotopes in the Neutron Energy Ranges Up To A Few Kev

In support of the Nuclear Criticality Safety Program, a set of evaluated resonance parameters was generated for seven dysprosium isotopes in the neutron energy range from thermal up to a few keV. The evaluation methodology used the Reich-Moore approximation to fit, with the R-matrix code SAMMY, the high-resolution capture and transmission measurements on natural and enriched samples recently performed at the Rensselaer Polytechnic Institute Gaerttner LINear ACcelerator facility. Additional transmission data measured on enriched samples by Liou at the Columbia University Nevis synchrocyclotron in the mid-seventies were used to gauge the neutron widths above 15 eV. Thermal constants such as absorption and (in)coherent scattering cross sections and corresponding scattering lengths were calibrated to the National Institute of Standards and Technology’s compilation except for 161,164 Dy isotopes.

07 ISOTOPE AND RADIATION SOURCES↗

The CEBAF e{sup +} Footprint

The Continuous Electron Beam Accelerator Facility (CEBAF) at the Jefferson Laboratory (JLAB) is capable of accelerating e{sup -} to 6 GeV in energy. Presently CEBAF is being upgraded to a maximum energy of 12 GeV. In addition to e{sup -} scattering, the user community has expressed interest in performing e{sup +} scattering experiments with the upgraded CEBAF accelerator. This paper describes the existing and planned CEBAF accelerator complex, possible e{sup +} production locations and the expected e{sup +} beam qualities. Possibilities for production of e{sup +} at the JLAB free electron laser (FEL) is also briefly described.

43 PARTICLE ACCELERATORS↗